Combino News

News list

Launch of Levetiracetam


May 15, 2012
Launch of Levetiracetam

COMBINO PHARM launches LEVETIRACETAM COMBINO PHARM 100MG/ML onto the market in 5ml vials. An antiepileptic intravenous drug to control crises for longer than other antiepileptic drugs.

LEVETIRACETAM COMBINO PHARM, presented in a box containing 10 vials with latex-free caps and anti-coring and with a "flip-off" capsule to guarantee the product has not been tampered with.

The full name of the speciality is LEVETIRACETAM COMBINO PHARM 100mg/ml concentrate for generic perfusion solution. The national code and unit Ex-factory Price (EFP) of the presentation is C.N. 687637.4, unit EFP 8.10€, which is a saving of 40% with regard to the innovative product (Keppra(r) -UCB).

COMBINO PHARM expects this new analgesic to lead to cost savings for hospitals in Spain.


Send us your comment
Full Name *
E-mail *
Comment *